We report glucocorticoid-dependent induction of transcription from the herpes simplex virus thymidine kinase gene promoter proximal regulatory region in the absence of glucocorticoid response elements and independent of the ability of glucocorticoid receptor (GR) to bind DNA. Examination of the thymidine kinase promoter localized glucocorticoid responsiveness to a binding site for CCAAT enhancer-binding proteins (C/EBPs). Further analysis indicated that GR specifically potentiated the induction of transcription by C/EBP␤, but not C/EBP␣ or ␦, and that full induction could be obtained by the ligand-binding domain (LBD) of GR alone. C/EBP␤, but not C/EBP␣ or ␦, reciprocally potentiated transcriptional activation by DNAbound GR LBD. However, C/EBP␤ was unable to increase activation by a GR LBD with a short Cterminal truncation, indicating that the functional interaction between the two factors was dependent upon the GR AF-2. Surprisingly, despite the specificity in functional effects, all three C/EBPs bound indistinguishably to GR in GST pull-down and immunoprecipitation assays. Indeed, several nuclear receptors, including the estrogen (ER␣), progesterone, retinoic acid (RAR), and androgen receptors, displayed a similar potential to bind C/EBPs. Previous reports have demonstrated that ER␣ and RARs repress transcriptional activation by C/EBP␤ in ways that were dependent on their related AF-2 functions. Therefore, the GR AF-2 may encode functional features that distinguish the transcriptional regulatory potential of GR from that of ER and RAR. Finally, C/EBP binding mapped to the GR DNA-binding domain, which was not required for functional interaction with C/EBP␤. Thus, the potentiation of C/EBP␤-mediated transcription by GR would appear to require the presence of an intermediary factor. (Molecular Endo-
INTRODUCTION
Transcription of the herpes simplex virus thymidine kinase (HSV-tk) promoter (Ϫ109/ϩ51) is regulated by the synergistic interaction of CCAAT enhancer binding proteins (C/EBPs) and Sp1 (1) (2) (3) (4) . Sp1 is a ubiquitous transcription factor with a zinc-fingered DNA-binding region that activates transcription of many mammalian genes but is of particular importance for the transcription of constitutively expressed structural genes lacking a TATA box (5) .
By contrast, the C/EBPs are a subfamily of the tissue-restricted bZip transcription factors, which regulate transcription through CCAAT DNA sequence motifs (6) (7) (8) (9) . There are several C/EBPs genes and many different isoforms of the C/EBP proteins (1, (10) (11) (12) (13) . The bZip domains of most of the C/EBPs are highly conserved (8) . However, the remainder of the proteins vary considerably between individual family members. C/EBPs have been shown to play determining roles in the differentiation (14) and function of hepatocytes (15, 16) , adipogenesis (17) (18) (19) (20) (21) (22) (23) (24) , and the functional regulation and homeostatic control of lymphoid (19, 22) and hematopoietic cells (19) . Interestingly, C/EBP␤ (also known as NF-IL6, Il-6DBP, LAP, AGP/EBP, CRP2, and NF-M), but not C/EBP␣, has been shown to specifically interact with Sp1 in a manner that allows it to regulate transcription from the rat CYP2D5 P450 gene (25) .
HSV replication occurs more efficiently in cells treated with the synthetic glucocorticoid dexamethasone (dex) (26) . However, glucocorticoids have not previously been reported to directly induce or otherwise influence transcription of the viral tk gene.
Glucocorticoids mediate transcriptional regulation through an intracellular nuclear hormone receptor that binds as a homodimer with high affinity to specific glucocorticoid-responsive DNA sequences [glucocorticoid-responsive elements (GREs) (27, 28) ]. The promoter-proximal regulatory region of the tk gene does not contain a sequence resembling GRE (4) .
GR, like all nuclear receptors, is a modular protein with a central DNA-binding domain flanked by carboxy-and amino-terminal transcriptional regulatory functions (29-33). In the absence of hormone, glucocorticoid receptor (GR) normally occurs in the cytoplasm in a high molecular weight complex with heat shock proteins and immunophilins (34). Steroid binding induces a conformational change in the receptor ligand-binding domain (LBD), which promotes dissociation of the GR-heat shock protein complex and allows translocation of the free receptor to the nucleus (34).
The activation of transcription by nuclear receptors is accomplished through interactions with transcriptional coregulatory proteins that promote the modification of chromatin structure and that interact with the basal transcriptional machinery (35-37). While the Nterminal activation functions appear to be unique to each receptor, the AF-2 activation functions at the C terminus of GR and other nuclear receptors (38-43) interact in an overlapping manner with a series of transcriptional coactivator protein complexes that include proteins such as SRC-1 (44), CBP (45-47), and GRIP-1 (48, 49) and have histone acetylase activity (50, 51) . Interestingly, many other transcription factors also appear to interact with the same coactivator complexes. This creates the potential for competition by nuclear receptors and other transcription factors for a limited pool of coactivator molecules. For example, it is now clear that GR competes with other nuclear hormone receptors and transcription factors such as CREB and AP-1 for CBP-containing coactivator complexes (45, [52] [53] [54] . However, the differential interaction of transcription factors with common coactivators also may explain elements of the transcriptional synergism observed between nuclear receptors and other sequence-specific transcription factors on complex promoters.
Not all effects of GR on transcription result from the direct binding of receptor homodimers to canonical GREs. A number of transcriptional effects resulting from direct protein-protein interaction of GR with other sequence-specific transcription factors have been described. For example, direct interaction between GR and AP-1 has been demonstrated to be required to direct transcription from composite response elements that bind both factors together (55) . Transcription is enhanced or repressed by this complex, depending on the specific c-fos family member in the jun/fos AP-1 heterodimer (55) (56) (57) (58) . Recently, it also has been demonstrated that GR can act essentially as a coactivator to potentiate the activation of transcription from PRL-responsive promoters in the absence of a GRE by binding to DNA-bound Stat5 (59) .
In the present study we have determined that glucocorticoids activate transcription from the HSV-tk proximal promoter despite the absence of a GRE. The results of our analysis suggest that this effect is mediated through a functional interaction between the AF-2 of GR and C/EBP␤. These results contrast with the recent demonstrations that the AF-2 activities of retinoic acid receptor and estrogen receptor-␣ (ER␣) can act to repress C/EBP␤-mediated transcription (17, 60) . Therefore, our results indicate one way in which the GR AF-2 may be functionally distinct from the AF-2s of other steroid/retinoid receptors.
RESULTS

The HSV Promoter Is Activated by Glucocorticoids in the Absence of the Binding of GR to DNA
During the course of experiments examining the mechanism of transcriptional regulation by GR in Cos7 cells, we observed that the Ϫ109/ϩ51 sequence from the HSV-tk promoter was strongly inducible by dex in the presence of coexpressed GR (data not shown). This was unexpected because, although this region of the tk promoter contains two Sp1 DNA-binding sites and one C/EBP-binding site, it does not contain a discernible GRE (Fig. 1A) (3, 4) .
It has been demonstrated previously that N 6 methylation of adenine residues as a result of dam methylation of plasmids grown in dam ϩ strains of Escherichia coli can lead to the artefactual creation of cryptic GREs (61) . Therefore, to determine whether dam methylation had resulted in the creation of a cryptic GRE on our HSV-tk reporter plasmid, we repeated the transfections with a plasmid prepared in the dam -dcm -Rb404 E. coli strain (Fig. 1B) . Dex treatment of cells cotransfected with the tkCAT reporter and a rat GR expression plasmid resulted in a 4-fold induction of chloramphenicol acetyltransferase (CAT) activity (lane 1). Thus, the glucocorticoid responsiveness of the tk promoter was not due to dam methylation. The activation of transcription was dependent upon GR and hormone agonist, as no induction was detected in the absence of cotransfected receptor expression plasmid (lane 4) or when GR-expressing cells were treated with the glucocorticoid antagonist RU486 (lane 2). Further, androgen receptor (AR) was unable to substitute for GR (lane 3). Indeed, dihydrotestosterone (DHT) treatment of cells expressing AR reproducibly led to a 2-fold repression of CAT activity. Finally, to confirm that the observed effect was not due to treatment of the cells with high levels of dex, we repeated the experiment at 33 nM dex, the optimal concentration for the use of this glucocorticoid in the Cos7 parental line CV1 (62), with similar results (data not shown).
To confirm that this effect was mediated in the absence of GR binding to DNA and to begin to localize the determinants on GR required for this effect, we examined the transcriptional response of the tk promoter to three additional GR constructs (Fig. 2) . First, expression of full-length GR with an L501P mutation in the DNA-binding domain (DBD) that abrogates sequence-specific DNA binding (63) actually led to a slightly stronger response, with the induction of CAT activity from the tk promoter increased from 4-to 6-fold (lanes 1 and 2). However, expression of the N-terminal 525 amino acids of GR had no effect on reporter gene activity (lane 3). By contrast, N525 constitutively activates transcription from a GRE (64) . Finally, expression of a GR fragment N-terminally truncated at amino acid 547 at the border of the LBD was as efficient in activating tk transcription as WT GR (lane 4). Thus, the ligand-binding domain of GR appeared to be sufficient for full induction of tk expression.
GR Activates Transcription from the tk CCAAT Element
The tk promoter used in these experiments contains binding sites for both Sp1 and C/EBP (3). To determine whether the potentiation of tk transcription by GR was mediated through one of these sequences, we prepared two CAT constructs with a minimal adenovirus E1B minimal promoter and four copies of an Sp1-binding site or the C/EBP response element (Fig. 3,  top) . As a control, a similar construct was prepared with four copies of an octamer motif, which does not occur in the tk promoter. In addition, we also recloned the Ϫ109/Ϫ29 HSV-tk promoter-proximal regulatory region in front of the E1B promoter to determine whether similar effects could be detected with a heterologous promoter. Transfections were then performed to determine the response of these constructs to the activation of GR L501P by dex (Fig. 3, bottom) . In GR L501P -transfected cells, dex treatment failed to activate transcription appreciably from the SP1-responsive promoter or control construct with four octamer motifs inserted adjacent to the E1B sequence (lanes 1 and 2). By contrast, the CCAAT/E1B construct was hormone responsive, with dex treatment inducing CAT activity 4-fold (lane 3). This suggested that GR specifically targeted factors acting through the C/EBP-binding site in the tk promoter.
Interestingly, when placed adjacent to the E1B promoter, the promoter-proximal tk-regulatory region was only weakly responsive to GR L501P and dex, with CAT activity being induced just under 2-fold (lane 4). One possibility suggested by this result was that the minimal tk promoter was somehow also making an important contribution to the GR responsiveness. However, recloning the tk sequences into the E1B promoter also resulted in an increase in spacing of 16 bp between the DNA response elements in the tk region and the TATA box element. Thus it is also possible that the decreased response was due to this change in relative positioning of the tk response elements and the TATA box, which is equivalent to 1.5 turns of the DNA helix.
Finally, to determine whether the entire effect of GR on tk transcription was mediated through the C/EBPbinding site in the tk promoter, we determined the response of a Ϫ109 to ϩ51 tk reporter gene in which site-directed mutagenesis had been used to convert the C/EBP-binding site to a nonfunctional sequence that has previously been described (65) . Dex treatment of cells cotransfected with GR L501P and the HSV-tk C/EBP mut reporter plasmid was completely unable to induce reporter gene activity. Therefore, the C/EBP binding site in the tk promoter was both required for and sufficient for the induction of transcription by GR in Cos7 cells.
GR Potentiates the Activation of Transcription by C/EBP␤, but Not by C/EBP␣ or ␦
The results obtained in the experiment shown in Fig.  3 suggested that GR had the ability to potentiate the activation of transcription by one or more isoforms of C/EBP. To evaluate the selectivity of dex induction of transcription through the CCAAT element, we examined the effect of coexpressing GR L501P and three C/EBP proteins, C/EBP␣, ␤, and ␦, on the induction of transcription of the CCAAT/E1B CAT reporter gene (Fig. 4) . In the absence of dex, expression of C/EBP␣, ␤, and ␦ each resulted in a 5-to 8-fold induction of CAT activity. The same result was obtained in the absence of cotransfected GR, and no induction was observed on the parent E1B reporter construct lacking the CCAAT response elements (data not shown). Treatment of cells cotransfected to express C/EBP␣ or ␦ and GR L501P with dex had no significant additional effect on transcription (Fig. 4A, lanes 2 and 4) . However, when C/EBP␤ was coexpressed with GR L501P , dex treatment led to a strikingly further induction of transcription (lane 3). Reexpression of the data as fold induction by dex ( Fig. 4B ) highlights that GR L501P induced CAT activity 4-fold above the level induced by C/EBP␤, but had only a minimal effect on the transcription induced by C/EBP␣ and C/EBP␦. Cos7 cells were transfected with a vector expressing GR L501P and one of four E1B CAT reporter constructs or a construct with the tk promoter from Ϫ109 to ϩ51 with an inactivating mutation in the C/EBP binding site. The structure of these constructs is summarized at the top. The fold induction of CAT activity in response to treatment of the transfected cells with 0.2 M dex is shown at the bottom. Similar effects were observed at 33 nM dex.
Functional Interaction between GR and C/EBP␤ Requires the C-Terminal AF-2 Activity of GR
Our results indicated that the LBD of GR contained a hormone-dependent ability to potentiate the activation of transcription by C/EBP␤, in the absence of GR binding to DNA. One question raised by these results was whether C/EBP␤ could reciprocally potentiate the activation of transcription of DNA-bound GR in the absence of CCAAT response elements. To address this question, we tested the ability of the C/EBPs to potentiate the activation of transcription by a GR LBD construct fused to the yeast GAL4 DBD. This experiment was performed using a reporter gene with 5 GAL4-binding sites driving transcription from the E1B promoter (Fig. 5) .
Cotransfection of the C/EBP expression plasmids with pGalO, a plasmid expressing GAL4 DBD alone, had no effect on E1B expression (Fig. 5A, lanes 1 and  4-6) . Expression of the GAL-LBD construct in the presence of dex induced CAT activity approximately 8-fold above the level obtained with GalO (lane 2 Fig.  5 B, lane 1) . Coexpression of C/EBP␤ with GAL-LBD increased the induction of transcription in response to dex treatment a further 4-fold (Fig. 5B, lane 3) . By contrast, coexpression of C/EBP␣ or ␦ resulted in no significant additional transcriptional activation above the level induced by GAL-LBD alone (lanes 2 and 4). Therefore, while the potentiation of transcription again appeared to be a specific property of the GR LBD and C/EBP␤, which partner was tethered to DNA appeared to be unimportant.
The inability of RU486-treated GR to potentiate the activation of tk transcription ( Fig. 1) suggested that the GR-C/EBP␤ interaction could be linked to AF-2 function of GR, which is unresponsive to RU486. Deletion of 14 amino acids from the C-terminal end of GR inactivates the AF-2 function, with a decrease in ligand-binding affinity that can be compensated for by treatment with pharmacological concentrations of hormone (66) . To determine whether the AF-2 function of the GR LBD was required for C/EBP␤ to potentiate GAL-LBD-mediated E1B transcription, we repeated our experiment with GAL-LBD 781 (Fig. 5) . As expected, GAL-LBD 781 was ineffective in activating E1B transcription (Fig. 5A, lane 3) , and no additional activity was observed upon coexpression of C/EBP␣, or ␦ (Fig.  5B, lanes 6-8) . However, in this instance, coexpression of C/EBP␤ also failed to increase reporter gene transcription. Western blotting, shown in Fig. 5C , demonstrated that GAL-LBD and GAL-LBD 781 were expressed at similar levels. Thus, our results indicate that functional interaction between the GR LBD and C/EBP␤ was dependent on the integrity of the GR AF-2.
The Potentiation of C/EBP␤-Mediated Transcriptional Activation Occurs Independent of Binding to GR
To investigate whether the functional interactions observed between the GR LBD and C/EBP␤ might correlate with protein-protein interactions between the two factors, we tested the ability of in vitro translated GR peptides to bind to C/EBP␣ and C/EBP␤ expressed as GST fusion proteins. The results of this experiment are displayed in Fig. 6 . Contrary to expectations, full-length, dex-treated GR bound strongly to both C/EBPs, not just C/EBP␤ (lanes 1 and 8) . Deletion of the N terminus of GR up to the DBD (X795) had no effect on binding (lanes 2 and 9), nor did deletion of AF-2 (X781, lanes 3 and 10). Similarly, both C/EBPs were bound by a GR peptide containing amino acids 1-523 (lanes 6 and 13), a fragment of GR that was unable to potentiate C/EBP activity in transfection experiments (Fig. 2) . By contrast, the LBD of GR (547C), which was sufficient for the potentiation of C/EBP␤ activity in transfection experiments, failed to bind either C/EBP (lanes 5 and 12). Finally, a GR peptide containing only the DBD (X616) retained full C/EBPbinding activity in this assay (lanes 4 and 11) .
The binding of GR to C/EBP␤ and ␦ was investigated further by incubating in vitro translated C/EBPs with GR immunoprecipitated from fibroblasts expressing a stably transfected WT GR with an N-terminal C-myc antibody tag (Fig. 7) . To investigate the hormonal requirements for binding, GRs were prepared by salt extraction from cells treated with dex or RU486 and from untreated cells. In this experiment, both in vitro translated C/EBP␤ (Fig. 7 A) and C/EBP␦ (Fig. 7 B) were coimmunoprecipitated to approximately the same extent from all three extracts prepared from GR-positive cells (lanes 5-7), while little binding was detected in extracts prepared from control cells lacking GR (lanes 2-4) . In further contrast to the transcription results, C/EBP binding was the same for RU486-treated GRs and GRs transformed by heat and salt, as it was for dex-treated receptors.
C/EBP Binding Is a Conserved Property of Steroid/Retinoid Receptors
Two other nuclear hormone receptors in addition to GR, estrogen receptor-␣ (ER␣) and retinoic acid receptor-␥ (RAR␥), have been reported to interact functionally with C/EBP␤ in an AF-2-dependent manner (17, 60) . However, in contrast to the inductive effects Cos 7 cells were cotransfected with a G5E1BCAT reporter plasmid, GALGRLBD, and GALGRLBD 781 fusion protein expression plasmids and C/EBP expression plasmids as indicated to assess the ability of C/EBPs to potentiate the activation of transcription by the LBD of GR. Data are expressed relative to expression of the GAL4 DBD alone (A) or as fold induction in the presence of GAL-LBD fusion protein vs. the GAL4 DBD (B). All experiments were performed in the presence of 0.2 M dex, which is well above the concentration necessary to saturate GAL-LBD 781 . In panel C, the expression of levels of GAL-LBD and GAL-LBD 781 were compared by Western analysis of whole-cell extracts probed with GAL4 antibody (Santa Cruz). of GR, both ER␣ and RAR were observed to repress C/EBP␤-mediated transcription. Further, peptides including the DBD of ER␣ have previously been shown to bind to C/EBP␤ in vitro (60) . As GR bound C/EBP␤ in an apparently similar manner, we wondered whether C/EBP binding was a conserved property of steroid/ retinoid receptors. Our results, displayed in Fig. 8 , indicate that ER␣, AR, and retinoic acid receptor ␤ (RAR␤) also bound to both C/EBP␣ and ␤ in a GST pull-down assay. The same result was also obtained with RAR␥ (data not shown). By contrast, an unrelated transcription factor, nuclear factor 1, and firefly luciferase did not interact with the C/EBPs. Thus, it appears that the ability to bind C/EBPs is a property of several nuclear hormone receptors and may be important for the repression of C/EBP␤-activated transcription by ER␣, RAR, and potentially AR, but is dispensable for the potentiation of C/EBP␤-activated transcription by GR. However, the functional significance of this potential for direct binding between steroid/retinoid receptors and the three C/EBP isoforms remains to be completely elucidated.
DISCUSSION
Glucocorticoids and C/EBP␤ converge in the regulation of a large variety of cellular processes, including responses to inflammation and stress, and in tissue differentiation, e.g. differentiation of preadipocytes to mature adipocytes. It is well established that glucocorticoids and C/EBP␤ interact cooperatively in the regulation of the transcription of many of the genes whose induction contributes to these processes (67) (68) (69) . The results presented in this work suggest that cooperative interactions between C/EBP␤ and GR in the activation of specific gene transcription need not be dependent upon the close proximity of DNA-binding sites for each factor or upon direct protein-protein interactions between the two factors. Rather, they suggest that GR can potentiate the transcriptional regulatory potential of C/EBP␤ indirectly in a manner that is independent of DNA binding by GR. Indeed, this effect appeared to be dependent solely upon the receptor LBD. Moreover, the ability of C/EBP␤ to potentiate AF-2 dependent transcriptional activation by the DNA-bound GR LBD suggests that this process may be effective from both GREs and CCAAT-response elements. Interestingly, however, the transcriptional effects were specific for C/EBP␤, as neither C/EBP␣ nor C/EBP␦ interacted productively with GR in our experiments.
To date, three main mechanisms for the regulation of gene transcription by glucocorticoids have been established: direct activation through GREs; direct repression through negative GREs; and transcriptional interference resulting from the direct interaction of GR with other sequence-specific transcription factors (29, 70, 71). Our results suggest a fourth mechanism, transcriptional cooperativity mediated indirectly through an interaction between GR and the transcriptional machinery downstream from the binding of C/EBP␤ to DNA.
The activation of transcription by GR and C/EBP␤, like most transcription factors, is mediated through interactions with transcriptional coactivator molecules, proteins with histone acetyltransferase activity that do not bind DNA themselves, but function as bridging molecules between sequence-specific transcription factors and the basal transcriptional machinery (72, 73) . Recently, it has become apparent that many of these coactivator molecules exist in larger coregulatory complexes that include several different coactivator molecules (74) . For example, p300/CBP occurs in complexes with SRC-1, p/CAF, GRIP-1, and potentially other factors (75) .
The activation functions of many sequence-specific transcription factors bind directly to a variety of sites on individual coactivators (76) . Recently, it has been demonstrated that nuclear receptors and other transcription factors exhibit different requirements for coactivators within a coactivator complex, and it has been suggested that coactivator complexes exist in multiple alternative configurations (74) . Thus, liganded nuclear receptors, including GR, RAR, and ER␣, interact with p/CAF and SRC-1, while C/EBP␤ and CREB interact with p300/CBP (45, 49, 52, 74, 77, 78) .
Two schemes to explain how the functional interaction between GR and C/EBP␤ observed in our experiments might take place in the absence of DNA binding by GR are presented in Fig. 9 . As the reciprocal potentiation of transcriptional activation of GR and C/EBP␤ in our experiments was mediated indirectly, and both factors interact differently with coactivators that occur in the same complex, it is plausible that the functional interaction between GR and C/EBP␤ occurred at the level of the coactivator complex (Fig. 9,  panel 1) . In this scenario, in response to dex treatment, liganded GR interacting at a second site on the C/EBP␤-coactivator complex would enhance the ability of the coactivators to activate transcription. The effect on transcriptional activation could be mediated allosterically or by inducing changes in the composition of the complex. Certainly, the feasibility for the formation of such a complex has been established (74, 79) . It should also be noted that this model also suggests a mechanism for transcriptional synergism when both GR and C/EBP␤ are bound to DNA. In this instance, the binding of GR and C/EBP␤ to DNA might In vitro translated, 35 S-labeled proteins were incubated with GST-C/EBP␣ (A), GST-C/EBP␤ (B), or GST alone (C). Specifically bound proteins were resolved by 10% SDS-PAGE gels. Panel D shows 10% of the proteins added to the binding assay. All gels were exposed equally. Before binding, the nuclear receptors were pretreated with specific ligands as described in Materials and Methods.
be expected to further stabilize the recruitment of the larger regulatory complex.
A second possibility (Fig. 9 , panel 2) would be that GR interacts with a molecule [X] that acts negatively downstream from the C/EBP␤-coactivator complex to decrease transcriptional activation. In this instance, GR would remove or titrate a block on the communication of the C/EBP␤-coactivator complex with basal transcription factors. This possibility seems less likely as there are presently no potential candidates for this activity. Interestingly, one potential compromise between these two possibilities is that the binding of GR to the coactivator complex could relieve a repressive activity that occurs directly within the coactivator complex.
Our results clearly dissociated the binding of GR to C/EBP␤ from the potentiation of C/EBP␤-mediated transcription. Indeed, the minimum GR fragment required for the potentiation of transcription activated by C/EBP␤ was the only GR fragment tested in binding assays that failed to bind C/EBP␤. Further GR also bound to C/EBP␣ and C/EBP␦, but had no effect on the activation of transcription by these factors under our experimental conditions. These results clearly sever the previously proposed linkage between GR-C/EBP␤ binding and the potentiation of C/EBP␤-me- C/EBP␤ is known to interact with p300/CBP, transcriptional coactivator molecules that occur within larger transcriptional coactivator complexes that include molecules such as SRC-1, p/CAF, and GRIP-1. SRC-1 and potentially other molecules in the complex are also direct targets of the AF-2 domain of GR. In the first scenario (panel 1), upon ligand binding, GR enters into the coactivator complex that is associated with C/EBP␤ and acts to stimulate the activity of this complex. Possible mechanisms for this effect are discussed in the text. In a second scenario (panel 2), the GR AF-2 domain interacts with a factor (X) still unknown, but that functions in the context of the coactivator complex, or downstream from the complex, to decrease the efficiency of C/EBP␤-mediated transcriptional activation. diated transcription. However, it remains possible that GR-C/EBP binding will prove to be biologically relevant in other cell types or in response to additional signaling molecules not included in the present study. Alternatively, it is also possible that the binding observed here for C/EBP␣, ␤, and ␦, and reported previously for C/EBP␤, does not reflect a productive association between these factors in the cell.
In the present study, we observed that GR-C/EBP␤ binding in vitro requires the GR DBD, while a previous study demonstrated that binding required the bZIP DBD of C/EBP␤ (80) . As this is the conserved region of the C/EBPs, it would seem probable that the binding of GR to C/EBP␣ and ␦ would also be to the bZIP domain. Thus, a third possibility would be that the binding of the C/EBPs to DNA could interfere with the protein-protein interaction with GR. The DBDs of some factors, including GR, can simultaneously accommodate protein-protein and protein-DNA interactions (59, (80) (81) (82) (83) (84) (85) . By contrast, we have recently demonstrated that a direct interaction between the GR DBD and the POU DNA binding domain of transcription factors Oct-1 and Oct-2 was dissociated by the binding of GR to a GRE (86) . For GR and the octamer factors, the protein-protein interaction is nonetheless productive, as it serves to promote the binding of the octamer factors to response elements adjacent to DNA-binding sites for GR. Thus determining how GR-C/EBP binding responds to the presentation of GREs and CCAAT elements may suggest how this interaction might occur productively in the cell.
While GR potentiates the ability of C/EBP␤ to activate transcription, there are reports that ER␣ and RAR act to repress the activation of transcription by C/EBP␤ (17, 60) . In our study, we also observed that AR repressed the activation of transcription by C/EBP␤ and that RAR␤, ER␣, and AR bound C/EBP␤ similarly to GR. For ER␣ and RAR, repression also required AF-2 (17, 60), which would appear to suggest a difference in the function of the AF-2 of GR and that of ER␣ and RAR. For example, it is possible that the differences in effect reflect differences in the association of GR and ER␣-RAR with a common coactivator complex.
For ER␣, however, the repression of transcription induced by C/EBP␤ also was dependent upon the receptor DBD (60) . Indeed, we note that, upon deletion of the DBD, ER␣ reverted from a repressor of C/EBP␤-induced transcription to an activator similar to GR. Thus a second possibility is that the difference in the effect of ER␣ and GR on C/EBP␤ may be explained by differences in the way ER and GR bind to C/EBP␤. A resolution of the molecular basis for the differences in the interaction of GR, ER␣, and RAR with C/EBP␤ will require a direct comparative study of their individual effects.
GR is required for viability, as mice lacking a GR gene die shortly after birth from a defect that results in the lack of production of surfactant proteins in the lung (87) . The recent demonstration, that mutant GRs compromised for DNA-binding and DNA-dependent dimerization are viable (88) , highlights that many important functional activities of GR are mediated in the absence of direct contact of the receptor with DNA. The most intensively investigated DNA-independent effects of GR have been in the interference with the activities of NFB and AP1. Our results suggest that potentiation of the transactivation potential of C/EBP␤ may be another important way in which GR may exert physiological effects in the absence of DNA binding. Functional interaction between GR and C/EBP␤ is most obvious in their effects on inflammation and in the differentiation of preadipocytes. It will be interesting to determine to what degree the effects of glucocorticoids on these processes are dependent on the interaction between GR and C/EBP␤ reported here.
MATERIALS AND METHODS
Plasmids
The rat GR eukaryotic expression constructs, p6RGR (89), p6RGRN525 (64) , and p547C (90), have been previously described. Other constructs were derived from these vectors as described below. p6RGRL501P was created by site-directed mutagenesis of a p6RGR DNA fragment. pGaLLBD and pGaLLBD 781 were created by PCR amplification of GR LBD fragments encoding amino acids 540-795 and 540-781, respectively, into the SalI-XbaI sites of pGalO (91) . C/EBP expression vectors pMSV C/EBP␣, ␤, and ␦ have been previously described (9) . The rat AR was expressed from pSV40 AR (92) . The HSV-tk CAT reporter vector was essentially that previously described containing HSV-tk sequences Ϫ109/ ϩ51 (93). Adenovirus E1B reporter constructs were prepared by cloning into the XbaI site at Ϫ45 adjacent to the minimal E1B promoter of pG5E1BCAT (94) . Four copies of C/EBP (5Ј-CTA GGA GTG TCA TTG GCG AGG-3Ј) binding sites, octamer motifs (5Ј-AGGAGC TTG CTT ATG CAA ATA AGG TG-3Ј), and Sp1 (5Ј-CTA GCG ACC CCG CCC AGC GTG-3Ј) binding sites were cloned into pG5E1BCAT to generate p4Sp1G5E1BCAT, p4C/EBPG5E1BCAT, and p4OctG5E1BCAT reporter plasmids. PCR amplification was used to clone the Ϫ109/Ϫ29 promoter-proximal regulatory region of HSV-tk adjacent to the E1B promoter at Ϫ45 in pG5E1BCAT to generate pG5tkE1BCAT. Mutagenesis of the C/EBP␤ response element in the tk promoter was performed by changing the sequence of the CCAAT element at Ϫ88 to Ϫ90 -GAGTCGGACA-80 (65) , by performing PCR amplification with a mutated oligo and recloning the amplified product into the BamHI/RsrII sites of original HSV-tkCAT reporter gene. All constructs were verified by DNA sequencing. In all experiments pRSV ␤-gal was cotransfected to monitor transfection efficiency. C/EBP␤ and C/EBP␦ plasmids for in vitro translation were created by isolating EcoRI/BamHI ␤ and ␦ fragments from pMSVC/EBP ␤ and ␦ and recloning into pGEM-7Z (Promega, Madison, WI).
The plasmids used for in vitro translations, GRWT (pRDN93) (95) , X795, X781, X616, and 547C (66), have all been described previously. N523 was generated by digesting T7N556 (66) with PstI. The AR (92) , ER (96) , RAR␤ (97) , and nuclear factor 1 (98) vectors have been described previously. pSP6Luciferase was from Promega. The pTL-MTG GR expression vector has been described previously (86) .
In initial experiments, and for all plasmids not used as reporters in transient transfections, DNA was prepared from E. coli-DH5␣. Reporter plasmids were prepared from E. coli Rb404 (strain) to preclude the presence of cryptic GRE resulting from bacterial methylation (61) .
Transient Transfection Analyses
Cos 7 cells were maintained in DMEM containing 10% FBS at 37 C. Sixteen hours before transfection, 2 ϫ 10 5 cells were seeded onto 35-mm plates. Transfections were performed using Lipofectamine (Life Technologies, Gaithersburg, MD; 5 l per 35-mm plate). Each transfection was performed using 0.3 g CAT reporter plasmid, 0.3 g ␤-galactosidase reporter, and, as indicated, 0.6 g steroid receptor expression plasmids and 0.3 g C/EBP expression plasmids. Sixteen hours posttransfection, the medium was replaced with DMEM-10% FBS supplemented with steroidal ligands or ethanol alone as described in individual experiments. Dex (Steraloids, Wilton, NH) was added to 0.2 M, RU38486 (RU486) was added to 1.0 M, and DHT (Steraloids) was added to 0.05 M. In selected transfections the lower concentration of 33 nM dex was used with similar results. Cells were then allowed to grow for an additional 48 h.
␤-Galactosidase (used to normalize results for variations in transfection efficiency) and CAT assays were performed essentially as previously described (86) . Conversion of acetylated chloramphenicol was quantified using phosphorimager analysis (Bio-Rad, Richmond, CA). CAT activity was corrected for ␤-activity. Each data point represents the average of a minimum of three independent experiments each performed in duplicate. All error bars represent the SEM.
GR-C/EBP Binding Assays
GST fusion proteins were prepared and purified on glutathione Sepharose essentially as described (23) .
35 S-labeled proteins were produced using the Coupled Transcription-Translation TNT Reticulocyte Lysate System (Promega). Steroid binding to in vitro translated receptors was done by adding 1 M all-trans-retinoic acid to RAR, DHT to AR, diethlystilbestrol (DES) to ER, and dex to GR for 2 h at 4 C. For GSTbinding assays, 35 S-labeled proteins were incubated with 0.5 g immobilized GST-fusion protein in 200 l binding buffer [(15 mM HEPES, pH 7.9, 60 mM KCl, 12% glycerol, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride] for 90 min at 4 C and washed three times. The proteins retained on the affinity matrix were eluted in SDS sample buffer, resolved by SDS-PAGE, and visualized by autoradiography. A fraction representing 10% of the in vitro translated proteins added to the binding assay was loaded on identical gels and exposed together with the gels containing the bound fractions.
For immunoprecipitation assays, myc-tagged GR was immunoprecipitated from cellular extracts of Sf-7 murine fibroblasts stably transfected with a vector expressing WT GR with an N-terminal myc tag (86) . The protein A-Sepharose beads complex was preblocked in 150 l binding buffer and 5 l rabbit reticulocyte lysate at 4 C for 2 min. Samples were then centrifuged at 4000 rpm (4 C), after which the precipitate was resuspended in another 150 l binding buffer. Equivalent amounts (as determined by phosphoimage analysis) of the desired in vitro translated C/EBP isoform were added and allowed to bind to the affinity-purified GR for 2 h at 4 C. Samples were washed three times with 500 l binding buffer. After the washes, samples were resuspended in 20 l SDS sample buffer, boiled for 5 min, and run on SDS-PAGE. The gel was then dried and bands were quantified by phosphorimager analysis. Binding to immunoprecipitates from MTG GR-containing extracts was compared with that of the parental Sf-7 cells, which do not express MTG GR. MTG GR loading in each experiment was confirmed by Western immunoblotting.
Western blotting for GR was done as previously described (99). After SDS-PAGE, protein samples were electroblotted from the SDS-PAGE gel to a polyvinylidene fluoride membrane. The primary antibody used was anti-myc antibody, 9E10 (1:2000 dilution). Detection of 9E10 signal was done by enhanced chemiluminescence (ECL, Amersham, Arlington Heights, IL) using horseradish peroxidase-conjugated sheep antimouse antibody (1:50,000 dilution) (Amersham), as the secondary antibody. Expression levels for the pGALO constructs were verified by Western blotting with the an anti-GAL4 antibody (Santa Cruz Biotechnology, Santa Cruz, CA). 
